STAT-related_JJ
transcription_NN
factors_NNS
are_VBP
constitutively_RB
activated_VBN
in_IN
peripheral_JJ
blood_NN
cells_NNS
from_IN
acute_JJ
leukemia_NN
patients_NNS
._.

A_DT
signal_NN
transduction_NN
pathway_NN
activated_VBN
by_IN
many_JJ
cytokines_NNS
has_VBZ
recently_RB
been_VBN
elaborated_VBN
._.

The_DT
JAK_NN
kinases_NNS
and_CC
the_DT
signal_NN
transducers_NNS
and_CC
activators_NNS
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
factors_NNS
have_VBP
been_VBN
found_VBN
to_TO
be_VB
essential_JJ
components_NNS
._.

In_IN
this_DT
report_NN
,_,
we_PRP
describe_VBP
the_DT
presence_NN
of_IN
constitutively_RB
activated_VBN
STAT_NN
factors_NNS
in_IN
peripheral_JJ
blood_NN
cells_NNS
from_IN
patients_NNS
with_IN
acute_JJ
leukemia_NN
._.

We_PRP
used_VBD
oligonucleotide_NN
probes_NNS
from_IN
the_DT
beta-casein_NN
and_CC
IRF-1_NN
gene_NN
promoters_NNS
and_CC
the_DT
ISRE_NN
probe_NN
to_TO
detect_VB
STAT_NN
proteins_NNS
in_IN
nuclear_JJ
extracts_NNS
from_IN
acute_JJ
leukemia_NN
cells_NNS
in_IN
bandshift_NN
assays_NNS
._.

Specific_JJ
DNA_NN
protein_NN
complex_NN
formation_NN
was_VBD
observed_VBN
with_IN
the_DT
probes_NNS
from_IN
the_DT
beta-casein_NN
and_CC
IRF-1_NN
gene_NN
promoters_NNS
,_,
but_CC
not_RB
with_IN
the_DT
ISRE_NN
oligonucleotide_NN
probe_NN
,_,
when_WRB
cell_NN
extracts_NNS
from_IN
acute_JJ
lymphoblastic_JJ
leukemia_NN
-LRB-_-LRB-
ALL_NN
-RRB-_-RRB-
and_CC
acute_JJ
myeloid_JJ
leukemia_NN
-LRB-_-LRB-
AML_NN
-RRB-_-RRB-
were_VBD
investigated_VBN
._.

We_PRP
used_VBD
nonradioactive_JJ
oligonucleotides_NNS
as_IN
competitors_NNS
to_TO
show_VB
the_DT
specificity_NN
of_IN
the_DT
complex_NN
formation_NN
._.

Specific_JJ
antibodies_NNS
directed_VBN
against_IN
the_DT
individual_JJ
STAT_NN
proteins_NNS
were_VBD
used_VBN
in_IN
supershift_NN
experiments_NNS
._.

STAT5_NN
-_:
and_CC
STAT1-related_JJ
factors_NNS
were_VBD
detected_VBN
in_IN
ALL_NN
and_CC
STAT1_NN
-_:
,_,
STAT3_NN
-_:
,_,
and_CC
STAT5-related_JJ
proteins_NNS
were_VBD
present_JJ
in_IN
nuclear_JJ
cell_NN
extracts_NNS
from_IN
AML_NN
._.

Since_IN
the_DT
cells_NNS
were_VBD
not_RB
treated_VBN
with_IN
cytokines_NNS
before_IN
the_DT
nuclear_JJ
proteins_NNS
were_VBD
extracted_VBN
,_,
we_PRP
conclude_VBP
that_IN
these_DT
factors_NNS
are_VBP
constitutively_RB
activated_VBN
in_FW
vivo_FW
._.

It_PRP
is_VBZ
likely_JJ
that_IN
the_DT
constitutive_JJ
activation_NN
of_IN
STAT_NN
proteins_NNS
is_VBZ
a_DT
part_NN
of_IN
the_DT
events_NNS
of_IN
leukemogenesis_NN
._.

